Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian S Ishkanian

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Acta Oncologica (Stockholm, Sweden)|July 2, 2010
Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancerAdrian S Ishkanian, Gaetano Zafarana, John Thoms, et al.
BMC Genomics|January 16, 2004
Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arraysSpencer K Watson, Ronald J deLeeuw, Adrian S Ishkanian, et al.
The Prostate|April 8, 2009
High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancerAdrian S Ishkanian, Chad A Mallof, James Ho, et al.
Nature Genetics|February 26, 2004
A tiling resolution DNA microarray with complete coverage of the human genomeAdrian S Ishkanian, Chad A Malloff, Spencer K Watson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2011
NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapyJennifer A Locke, Gaetano Zafarana, Adrian S Ishkanian, et al.
Cancer|January 28, 2012
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapyGaetano Zafarana, Adrian S Ishkanian, Chad A Malloff, et al.
The Lancet. Oncology|December 3, 2014
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort studyEmilie Lalonde, Adrian S Ishkanian, Jenna Sykes, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Acta Oncologica (Stockholm, Sweden)|July 2, 2010
Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancerAdrian S Ishkanian, Gaetano Zafarana, John Thoms, et al.
BMC Genomics|January 16, 2004
Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arraysSpencer K Watson, Ronald J deLeeuw, Adrian S Ishkanian, et al.
The Prostate|April 8, 2009
High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancerAdrian S Ishkanian, Chad A Mallof, James Ho, et al.
Nature Genetics|February 26, 2004
A tiling resolution DNA microarray with complete coverage of the human genomeAdrian S Ishkanian, Chad A Malloff, Spencer K Watson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2011
NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapyJennifer A Locke, Gaetano Zafarana, Adrian S Ishkanian, et al.
Cancer|January 28, 2012
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapyGaetano Zafarana, Adrian S Ishkanian, Chad A Malloff, et al.
The Lancet. Oncology|December 3, 2014
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort studyEmilie Lalonde, Adrian S Ishkanian, Jenna Sykes, et al.
Pageof 1